SureTrader
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

Nabriva Therapeutics AG (NBRV)

NBRV RSS Feed
Add NBRV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 11/4/2017 2:49:13 PM - Followers: 7 - Board type: Free - Posts Today: 0

Nabriva Therapeutics AG Leberstrasse 20 Vienna, 1110 Austria Phone: 43 1 740 93 0 Fax: 43 1 740 93 1900 Website: http://www.nabriva.com Nabriva Therapeutics AG, a clinical stage biopharmaceutical company, engages in the research and development of anti-infective agents to treat infections in humans. The company focuses on the pleuromutilin class of antibiotics. Its lead product candidate is lefamulin, which has completed a Phase II clinical trial for acute bacterial skin and skin structure infections. The company is developing intravenous and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia; and intends to develop lefamulin for additional indications other than pneumonia. It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007. Nabriva Therapeutics AG was incorporated in 2005 and is headquartered in Vienna, Austria.
SureTrader
Interactive Brokers Advertisement
NBRV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SureTrader
NBRV News: Securities Registration: Employee Benefit Plan (s-8) 12/12/2017 04:33:01 PM
NBRV News: Nabriva Therapeutics Announces Completion of Enrollment in LEAP 2, a Phase 3 Clinical Trial Evaluating Oral Lefamulin for the... 12/04/2017 07:00:00 AM
NBRV News: Statement of Changes in Beneficial Ownership (4) 12/01/2017 04:08:48 PM
NBRV News: Nabriva Therapeutics to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference 11/30/2017 07:00:00 AM
NBRV News: Quarterly Report (10-q) 11/09/2017 04:23:15 PM
News News Alert: Securities Registration: Employee Benefit Plan (s-8) 12/12/2017 04:33:01 PM
PostSubject
#10   did send ir email adobe 11/04/17 02:49:13 PM
#9   COULD not find on their site that they adobe 11/03/17 05:41:14 PM
#8   $10 plus next week; nymostwanted 09/22/17 08:45:21 PM
#7   https://seekingalpha.com/article/4108574-nabriva-looks-another-phase-3-seal-deal Inoviorulez 09/21/17 07:16:13 PM
#6   I am wanting to see above 14.10, just jet1968 09/20/17 04:13:37 PM
#5   Hoping to see a bigger bounce in the ilovestocks85 09/18/17 05:43:01 PM
#4   NBRV 9.49 bullish jet1968 09/18/17 02:03:13 PM
#3   Being Shorted to death after hitting $14s. runningwithscissors 09/18/17 10:17:23 AM
#2   Any Prediction of results due first half of J_Cali 08/29/17 10:34:57 PM
#1   NBRV bearish 7.38 stocktrademan 06/03/16 08:04:16 PM
PostSubject